Parsey MV - Search Results

1

Lebrikizumab treatment in adults with asthma.

Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG. Corren J, et al. Among authors: parsey mv. N Engl J Med. 2011 Sep 22;365(12):1088-98. doi: 10.1056/NEJMoa1106469. Epub 2011 Aug 3. N Engl J Med. 2011. PMID: 21812663 Free article. Clinical Trial.

2

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids.

Noonan M, Korenblat P, Mosesova S, Scheerens H, Arron JR, Zheng Y, Putnam WS, Parsey MV, Bohen SP, Matthews JG. Noonan M, et al. Among authors: parsey mv. J Allergy Clin Immunol. 2013 Sep;132(3):567-574.e12. doi: 10.1016/j.jaci.2013.03.051. Epub 2013 May 29. J Allergy Clin Immunol. 2013. PMID: 23726041 Clinical Trial.

3

A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.

Nowak R, Emerman C, Hanrahan JP, Parsey MV, Hanania NA, Claus R, Schaefer K, Baumgartner RA; XOPENEX Acute Severe Asthma Study Group. Nowak R, et al. Among authors: parsey mv. Am J Emerg Med. 2006 May;24(3):259-67. doi: 10.1016/j.ajem.2006.01.027. Am J Emerg Med. 2006. PMID: 16635694 Clinical Trial.

4

Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.

Berger WE, Milgrom H, Skoner DP, Tripp K, Parsey MV, Baumgartner RA; Xopenex Pediatric Asthma Group. Berger WE, et al. Among authors: parsey mv. Curr Med Res Opin. 2006 Jun;22(6):1217-26. doi: 10.1185/030079906X112534. Curr Med Res Opin. 2006. PMID: 16846555 Clinical Trial.

5

Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma.

Skoner DP, Greos LS, Kim KT, Roach JM, Parsey M, Baumgartner RA. Skoner DP, et al. Pediatr Pulmonol. 2005 Dec;40(6):477-86. doi: 10.1002/ppul.20288. Pediatr Pulmonol. 2005. PMID: 16193496 Clinical Trial.

6

Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.

Hamilos DL, D'Urzo A, Levy RJ, Marcus M, Tripp K, Parsey M, Baumgartner RA, McVicar WK. Hamilos DL, et al. Ann Allergy Asthma Immunol. 2007 Dec;99(6):540-8. doi: 10.1016/S1081-1206(10)60384-5. Ann Allergy Asthma Immunol. 2007. PMID: 18219836 Clinical Trial.

7

Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.

Donohue JF, Parsey MV, Andrews C, D'Urzo T, Sharma S, Schaefer K, Claus R, Baumgartner RA; Levalbuterol COPD Study Group. Donohue JF, et al. Among authors: parsey mv. COPD. 2006 Aug;3(3):125-32. doi: 10.1080/15412550600829190. COPD. 2006. PMID: 17240614 Clinical Trial.

8

Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1beta.

Parsey MV, Kaneko D, Shenkar R, Abraham E. Parsey MV, et al. Chest. 1999 Jul;116(1 Suppl):67S-68S. doi: 10.1378/chest.116.suppl_1.67s. Chest. 1999. PMID: 10424597 No abstract available.

9

Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of IL-1beta.

Parsey MV, Kaneko D, Shenkar R, Abraham E. Parsey MV, et al. Clin Immunol. 1999 May;91(2):219-25. doi: 10.1006/clim.1999.4693. Clin Immunol. 1999. PMID: 10227814

10

Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia.

Parsey MV, Tuder RM, Abraham E. Parsey MV, et al. J Immunol. 1998 Jan 15;160(2):1007-13. J Immunol. 1998. PMID: 9551941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page